Brief: China Pioneer Pharma Announces Agreement With A Co Based In U.S.
June 4 (Reuters) - China Pioneer Pharma Holdings Ltd
1345.HK :
* GROUP HAS NEWLY REACHED AGREEMENT WITH A CO BASED IN
UNITED
STATES
* SALES VOLUME IS USD18.5 MILLION IN TOTAL
* GROUP AGREED TO SELL KN95 PROTECTIVE FACE MASKS
* SALES EXPECTED TO BE COMPLETED AROUND OR BEFORE EARLY JULY
Source text for Eikon: urn:newsml:reuters.com:*:nHKS9ShMx2
Further company coverage: 1345.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Shanghai Pioneer Holding
See all newsBrief: Shanghai Pioneer Posts HY Revenue Rmb602.8 Million
Brief: Shanghai Pioneer Net Profit Rmb105.1 Million In 2025
Brief: Shanghai Pioneer To Be Exclusive Distributor Of Labo Hair Loss Vials In China
Brief: Shanghai Pioneer Logs H1 Gross Profit RMB 303 Mln
Brief: Shanghai Pioneer Expects 45%-48% Net Profit Decrease For HY